Medicare Advantage
Key Findings
- A large majority (76%) of survey respondents felt that bringing Medicare Advantage (MA) spending in line with traditional Medicare spending would substantially reduce the supplemental benefits offered by MA plans. Respondents were split on whether this would also reduce the number of MA plans available to beneficiaries or increase the cost to beneficiaries through higher premiums or cost sharing.
- A number of respondents who said that lowering MA spending would likely result in reductions in MA supplemental benefits noted that this may not necessarily be a negative outcome, given uncertainty about the value and utilization of these benefits.
- A plurality of experts (45%) disagreed or strongly disagreed that new requirements for MA plans to publicly report data on prior authorization would result in improvements in access to care for beneficiaries. Another 34% were uncertain about the impact of these requirements.
- More than half of experts (56%) agreed or strongly agreed that expanding traditional Medicare benefits to include dental and vision coverage would lead more beneficiaries to choose traditional Medicare instead of MA plans. Several of those who disagreed noted that other factors, such as limits on out-of-pocket spending, more insurer advertising and consumer engagement, and the simplicity of choosing a single plan, have a larger influence on MA enrollment.
Read the full Health Affairs Forefront summary of results here
Survey Questions
Please note: our surveys will consistently use two modifiers to describe the size of an effect: “Substantial”: when an effect is large enough to meaningfully influence policy decisions, program implementation, or outcomes of interest “Measurable”: when the direction of an effect is clear, but the effect may not be sufficiently large to make much of a difference for a given policy, program, or outcome.
The share of Medicare beneficiaries enrolled in Medicare Advantage (MA) has increased considerably over the past decade, from 31% in 2015 to 54% in 2025. During this period, total per-enrollee MA spending has risen faster than traditional Medicare spending, and policymakers are now considering or implementing program reforms. Meanwhile, several large MA insurers have announced that they will stop offering plans in some counties in 2026.
Response rate of 98% (62 out of 63 panelists responded)
Question 1:
Bringing total MA spending in line with total traditional Medicare spending would: (select all that apply)
a. Substantially reduce the number of MA plans available to consumers
b. Substantially reduce the supplemental benefits offered by plans
c. Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing
d. None of the above
e. No opinion

Question 2: Starting in 2026, MA insurers will be required to publicly report some data on prior authorization denials, approvals, and appeals. This will produce substantial improvements in access to care for beneficiaries.
a. Strongly Agree
b. Agreer
c. Uncertain
d. Disagree
e. Strongly Disagree
f. No Opinion

Question 3: Expanding traditional Medicare benefits to include dental and vision coverage would lead substantially more beneficiaries to choose traditional Medicare coverage instead of MA plans.
a. Strongly Agree
b. Agreer
c. Uncertain
d. Disagree
e. Strongly Disagree
f. No Opinion

Individual Survey Responses
Question One
Bringing total MA spending in line with total traditional Medicare spending would: (select all that apply)
| Name | Vote | Confidence | Comments | |
|---|---|---|---|---|
| Margarita Alegria | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 6 | ||
| David Asch | Substantially reduce the supplemental benefits offered by plans | 4 | I don’t have a good understand of the selection effects that are responsible for people’s decision to use these plans. I think a lot of people are attracted to what seem like more comprehensive benefits but also a lot of people are blindly induced into thinking these plans are the only way to go. While this comment is not responsive to the question, it seems central to the issue. | |
| John Ayanian | Substantially reduce the supplemental benefits offered by plans | 5 | ||
| Peter Bach | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 7 | ||
| Laurence Baker | Substantially reduce the supplemental benefits offered by plans | 6 | ||
| David Blumenthal | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 7 | The term “in line with” is vague. If it means “equal to”, then my responses hold. If it means higher but closer, then the effects are modified. | |
| Erin Fuse Brown | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 4 | Pretty confident that reducing MA spending to TM levels would reduce the number of MA plans available, but unclear whether that is a bad outcome as a policy matter because there are too many plan choices currently. Much less confident about the magnitude of the reduction of supplemental benefits (i.e., whether it would be “substantial” or not). | |
| Melinda Buntin | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 8 | ||
| Michael F. Cannon | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 6 | Could also result in narrower networks, etc. | |
| Lawrence Casalino | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | Expansion of MA has been made possible by overpayments. | |
| Amitabh Chandra | Did not answer | |||
| Lanhee J. Chen | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 7 | ||
| Michael Chernew | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 7 | The issue is what substantially, means. i view this proposal as suggesting about a 20% cut. If half passed through, that’s 10% and I consider that substantial | |
| Janet Currie | Substantially reduce the number of MA plans available to consumers | 6 | I’m assuming you mean spending per beneficiary. I believe that plans will still have an incentive to cream skim through their choice of supplemental benefits and/or cost sharing provisions, so the main effect would be on number of plans. | |
| Lesley Curtis | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 5 | ||
| David Cutler | Substantially reduce the supplemental benefits offered by plans | 6 | ||
| Julie Donohue | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing | 6 | ||
| Joseph Doyle | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 6 | Risk adjustment is very important consideration in how the impacts would be felt. | |
| David Dranove | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 9 | ||
| Stacie Dusetzina | Substantially reduce the supplemental benefits offered by plans | 6 | I believe MA plans would reduce supplemental benefit generosity rather than increase cost sharing in order to continue to attract beneficiaries. | |
| Jose Esarce | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 8 | ||
| Elliott Fisher | None of the above | 6 | I suspect that the plans will assert that all 3 are likely. The key question is whether that will in fact be harmful to Medicare beneficiaries and to the Medicare program overall. | |
| Richard Frank | Substantially reduce the supplemental benefits offered by plans | 6 | ||
| Craig Garthwaite | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 7 | While the rhetoric is often that the spending gap between MA and FFS is leading to excess profits for firms, I believe the real story is a bit more complicated. They do seem to have fueled an arms race in supplemental benefits – some of which are of dubious value. They have also resulted in insurance products that are far more complete than FFS. It is unclear which dimensions of the plans would be curtailed, though it is likely to be a mixture of benefit changes, cost sharing increases and/or exits from some markets. | |
| Darrell Gaskin | Substantially reduce the supplemental benefits offered by plans | 7 | MA beneficiaries are too price sensitive for MA plans to increase premiums and cost sharing. Even with a slow in MA spending, MA plans will be profitable. Savings will come from providers and supplemental benefits that beneficiaries don’t use. | |
| Martin Gaynor | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 8 | Reducing MA spending would very likely reduce the number of MA plans, although it’s unclear how large the effect would be. | |
| Sherry Glied | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the supplemental benefits offered by plans | 6 | ||
| David Grabowski | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 7 | ||
| Jonathan Gruber | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 5 | ||
| Vivian Ho | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 5 | So much of the outcome depends upon CMS’ ability to reduce the ability of some insurers to game the system. There are clearly excess profits in MA, so spending can be lowered while maintaining supplementary benefits. But CMS so far has shown little appetite for controlling upcoding and denials. | |
| Jason Hockenberry | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 9 | ||
| Haiden Huskamp | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers | 8 | ||
| Benedic Ippolito | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | ||
| Anupam Jena | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers | 6 | ||
| Nancy Keating | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 4 | I expect that there will be fewer plans available, fewer supplemental benefits, and higher premiums and cost sharing, but would have preferred the modifier to be “measurably” instead of “substantially”. | |
| Aaron Kesselheim | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 5 | ||
| Jonathan Kolstad | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | ||
| R Tamara Konetzka | None of the above | 6 | It is likely that some supplemental benefits would be reduced, and/or that cost sharing would increase, but whether these changes are substantial remains to be seen. Furthermore, since the use and value of the extra benefits is uncertain, a reduction would not necessarily be bad for Medicare overall. Similarly, a reduction in the number of MA plans in some markets would not necessarily be a bad thing. The key point here may be heterogeneity — a minority of MA enrollees in some plans and some markets may be worse off under this change, but on average it seems a worthy and necessary goal. | |
| Rick Kronick | None of the above | 4 | I don’t think the difference between MA spending and TM spending, especially after the implementation of V28, is as large as is sometimes assumed. Bringing MA spending in line with TM spending may not require large changes in MA payment. Further, early evidence about the effects of V28 in 2024 and 2025 suggests that it did not have a large effect on supplemental benefits, cost-sharing, or premiums. | |
| Valerie Lewis | No Opinion | 0 | ||
| Nicole Maestas | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 10 | ||
| Tom McGuire | None of the above | 7 | ||
| Ellen Meara | Substantially reduce the number of MA plans available to consumers | 4 | ||
| Ateev Mehrotra | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | We are already seeing that MA plans will cut benefits and pull out of some markets. But the key is that this is not necessarily a bad thing. | |
| David Meltzer | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 9 | ||
| Joseph Newhouse | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 9 | ||
| Sean Nicholson | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing | 7 | ||
| Steve Parente | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 9 | I studied Medicare HMO Exit with RWJ funding from 1999 to 2003 and have empirical evidence to back up my claims. | |
| Stephen Patrick | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 6 | I think the market could respond in different ways. I suspect fewer plans would be in the market if the incentives are not aligned. | |
| Harold Pollack | Substantially reduce the supplemental benefits offered by plans | 2 | Implementation details matter here. My own opinion is not particularly valuable when compared with others who bring more granular expertise. | |
| Daniel Polsky | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | Carriers have pressure to maintain their margins and will adjust to do so. | |
| Ninez Ponce | No Opinion | 0 | ||
| Thomas Rice | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 6 | ||
| Meredith Rosenthal | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers | 6 | In theory cutting MA payments could have all of these effects. whether it does or not depends on how large the rents are to MA now so it is a bit unknown. I have high confidence that at least one of these things will occur but it is unclear what the balance will be. I think the supplemental benefits are mostly about attracting healthy beneficiaries (cream skimming) and are not much used in practice so these seem less likely to be cut. | |
| Joseph Ross | None of the above | 5 | If spending were aligned with traditional Medicare, more plans would be profitable and supplemental services could still be offered. | |
| Brendan Saloner | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers | 3 | ||
| Kosali Simon | Substantially reduce the supplemental benefits offered by plans | 7 | A point to consider would be how welfare enhancing we think different supplemental benefits currently offered are. | |
| Jon Skinner | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 7 | ||
| Ben Sommers | Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 5 | hinges on the phrase ‘substantial,’ and also whether this is primarily accomplished by reducing MA payment, adding TM benefits, or a combination. | |
| Neeraj Sood | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | I am assuming a 20% rate cut which is unprecedented. | |
| David Stevenson | Substantially reduce the supplemental benefits offered by plans | 5 | ||
| Kevin Volpp | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 8 | ||
| Rachel Werner | Substantially increase cost to MA beneficiaries through higher premiums or cost-sharing, Substantially reduce the number of MA plans available to consumers, Substantially reduce the supplemental benefits offered by plans | 3 |
Question Two
Starting in 2026, MA insurers will be required to publicly report some data on prior authorization denials, approvals, and appeals. This will produce substantial improvements in access to care for beneficiaries.
| Name | Vote | Confidence | Comments |
|---|---|---|---|
| Margarita Alegria | Agree | 9 | |
| David Asch | Disagree | 5 | I am not sure customers will attend to this enough to motivate a change in MA plan behavior. |
| John Ayanian | Uncertain | 3 | |
| Peter Bach | Uncertain | 6 | |
| Laurence Baker | Disagree | 7 | |
| David Blumenthal | Agree | 6 | |
| Erin Fuse Brown | Disagree | 8 | |
| Melinda Buntin | Uncertain | 8 | |
| Michael F. Cannon | Strongly Disagree | 8 | Why should we suppose Medicare will measure this any better than it measures other dimensions of quality? |
| Lawrence Casalino | Uncertain | 5 | |
| Amitabh Chandra | Did not answer | ||
| Lanhee J. Chen | Uncertain | 8 | |
| Michael Chernew | Uncertain | 10 | I am sure I am uncertain. I lean towards disagree, |
| Janet Currie | Agree | 6 | I don’t think there is strong evidence about this, but we do know that many plans have a high level of denials for care that should be allowed. |
| Lesley Curtis | Agree | 6 | |
| David Cutler | Agree | 6 | |
| Julie Donohue | Uncertain | 8 | Public reporting in other health insurance markets hasn’t always led to big changes. |
| Joseph Doyle | Disagree | 8 | |
| David Dranove | Disagree | 7 | |
| Stacie Dusetzina | Disagree | 6 | I believe that reporting would need to have a financial impact (e.g., reduce start rating / bonus) to result in changes to beneficiary experience. |
| Jose Esarce | Uncertain | 7 | |
| Elliott Fisher | Disagree | 8 | |
| Richard Frank | Disagree | 8 | |
| Craig Garthwaite | Disagree | 5 | |
| Darrell Gaskin | Uncertain | 4 | |
| Martin Gaynor | Agree | 6 | Plans’ fears of negative publicity will probably result in fewer denials of care, although it’s not clear that beneficiaries will know about this information or if they will use it. It’s also likely that plans will find other ways to reduce utilization, so it’s not clear if access will increase and costs to beneficiaries may go up. |
| Sherry Glied | Strongly Disagree | 8 | Prior evidence suggests this sort of information is rarely consulted. |
| David Grabowski | Agree | 7 | I am very much in favor of the collection of these data but worry about whether they will move the needle in terms of access. |
| Jonathan Gruber | Uncertain | 10 | |
| Vivian Ho | Uncertain | 10 | |
| Jason Hockenberry | Disagree | 7 | I expect that this will lead to efforts to further narrow networks. |
| Haiden Huskamp | Disagree | 6 | |
| Benedic Ippolito | Uncertain | 1 | |
| Anupam Jena | Uncertain | 6 | |
| Nancy Keating | Uncertain | 5 | Glad to see some action on prior authorization, but I think we need time to understand how plans respond to the new requirements; I am not yet convinced that we’ll see substantial benefits to patients. |
| Aaron Kesselheim | Disagree | 7 | Transparency of this type may be important but is less likely to lead to ‘substantial improvements’ for patients than more thoughtful direct regulation (appeals in particular are less common) |
| Jonathan Kolstad | Disagree | 8 | Information alone has not been shown to drive demand to improve product innovation and design |
| R Tamara Konetzka | Disagree | 7 | Having these data will be good, but won’t necessarily change access unless the data lead to changes in policy. Furthermore, the data won’t reflect the full effects of prior auth and denials — the provider burden and behavior changes (avoiding treatments that will require prior auth). |
| Rick Kronick | Disagree | 5 | Increased scrutiny on prior authorization and appeals is certainly desirable, and attention from CMS and the public will likely result in some improvements in decision making processes. However, it will be difficult to assure that statistics on denials and appeals are fully comparable across MA plans or over time, and, at a minimum, it will likely take some number of years before the statistics are seen as fully credible. |
| Valerie Lewis | Uncertain | 10 | I think this is an important step, but the literature on public reporting and its effects show sometimes it doesn’t have intended effects. So while I think this moves toward better access, I suspect much more would be needed and public reporting alone may be gamed or have uncertain effects. |
| Nicole Maestas | Disagree | 6 | Most likely this would cause some beneficiaries to shift from denying plans to approving plans. Some denying plans will exit. Approving plans will in turn have to deny more to constrain costs. |
| Tom McGuire | Disagree | 7 | |
| Ellen Meara | Disagree | 8 | |
| Ateev Mehrotra | Uncertain | 6 | |
| David Meltzer | Agree | 8 | |
| Joseph Newhouse | Strongly Disagree | 9 | Most denials are for incomplete information or for services not covered in the contract. The former, of course, are often ultimately approved. |
| Sean Nicholson | Disagree | 8 | |
| Steve Parente | Uncertain | 8 | It’s unclear what consumers will find useful from the data to change behavior. |
| Stephen Patrick | Disagree | 8 | I’m skeptical this will make a meaningful change. It’s a positive step, but requires consumers to respond to the information. |
| Harold Pollack | Agree | 4 | This appears to be a good idea. The general equilibrium impacts are less clear. |
| Daniel Polsky | Disagree | 7 | Pressure to reduce prior auth will also affect margins for carriers which will reduce access as described in #1. This will be broader than the more noticible, but less frequent, unfair denials that get avoided by a policy like the one described. |
| Ninez Ponce | Agree | 8 | |
| Thomas Rice | Uncertain | 8 | |
| Meredith Rosenthal | Disagree | 10 | Transparency is rarely effective and it will be hard to know what to make of these data. |
| Joseph Ross | Disagree | 8 | I don’t think that public reporting alone will change care for beneficiaries. |
| Brendan Saloner | Agree | 5 | |
| Kosali Simon | Uncertain | 6 | The reason is we don’t know if patients are able to see these factors transparently when they select plans, there is a lot of inertia |
| Jon Skinner | Disagree | 6 | |
| Ben Sommers | Agree | 7 | |
| Neeraj Sood | Uncertain | 5 | |
| David Stevenson | Disagree | 7 | |
| Kevin Volpp | Agree | 7 | |
| Rachel Werner | Uncertain | 5 |
Question Three
Expanding traditional Medicare benefits to include dental and vision coverage would lead substantially more beneficiaries to choose traditional Medicare coverage instead of MA plans.
| Name | Vote | Confidence | Comments |
|---|---|---|---|
| Margarita Alegria | Agree | 7 | |
| David Asch | Agree | 5 | |
| John Ayanian | Agree | 3 | |
| Peter Bach | Disagree | 8 | |
| Laurence Baker | Disagree | 7 | |
| David Blumenthal | Disagree | 8 | The appeal of MA includes but goes beyond vision and dental — limits on oop payments, simplicity of enrolling in one plan, and sophisticated advertising/marketing as we now see during open enrollment. |
| Erin Fuse Brown | Uncertain | 3 | It’s difficult to anticipate the movement of benes from MA to TM without knowing what levels of subsidies there would be, what the premiums would be (which may be more influential factor), and whether cost-sharing is capped in TM. |
| Melinda Buntin | Agree | 9 | |
| Michael F. Cannon | Uncertain | 5 | |
| Lawrence Casalino | Strongly Agree | 8 | Would depend on the extent to which costs to beneficiaries of traditional Medicare care increased. |
| Amitabh Chandra | Did not answer | ||
| Lanhee J. Chen | Disagree | 8 | |
| Michael Chernew | Agree | 6 | As long as costs don’t rise. Main caveat is Part D. A key issue is how benchmarks adjust. |
| Janet Currie | Agree | 6 | Again, I’m not sure how much direct evidence there is that people are choosing MA because of dental or vision benefits, but it does seem plausible that they would. |
| Lesley Curtis | Disagree | 4 | |
| David Cutler | Agree | 3 | |
| Julie Donohue | Agree | 7 | |
| Joseph Doyle | Agree | 7 | |
| David Dranove | Agree | 7 | |
| Stacie Dusetzina | Uncertain | 5 | Not as clear to me which supplemental benefits are driving MA uptake (versus overall lower costs, avoidance of Medigap premium, and promotion of MA plans). |
| Jose Esarce | Agree | 7 | |
| Elliott Fisher | Strongly Agree | 9 | |
| Richard Frank | Uncertain | 3 | |
| Craig Garthwaite | Agree | 6 | It does appear that dental in particular is a major selling point of MA plans – if this were available for FFS plans then it would change the value proposition for MA and its reduced network. |
| Darrell Gaskin | Agree | 8 | MA beneficiaries value these benefits. |
| Martin Gaynor | Agree | 7 | This seems likely, but if traditional Medicare plus a supplemental plan costs significantly more than MA (as it does now) then there may not be a substantial change. |
| Sherry Glied | Agree | 6 | |
| David Grabowski | Agree | 7 | |
| Jonathan Gruber | Strongly Agree | 8 | Assuming that rates adjust upwards to offset costs |
| Vivian Ho | Disagree | 8 | Seniors are price sensitive, but dental and vision is too small a portion of seniors’ total expected costs to generate a “substantial” response. |
| Jason Hockenberry | Uncertain | 8 | It’s not clear that these are the main drivers of beneficiaries electing MA plans over TM. |
| Haiden Huskamp | Disagree | 5 | |
| Benedic Ippolito | Uncertain | 7 | Depends if and how this affects MA benchmarks and subsequent plan generosity in MA |
| Anupam Jena | Uncertain | 6 | |
| Nancy Keating | Agree | 5 | It will depend in part on how much premiums increase with these additions and how traditional Medicare compares with Medicare Advantage options. |
| Aaron Kesselheim | Uncertain | 7 | We should do this, of course, but whether it will be the deciding factor for “substantially” more patients is unclear to me |
| Jonathan Kolstad | Disagree | 8 | |
| R Tamara Konetzka | Agree | 8 | These extra benefits are often cited as reasons that beneficiaries choose MA, so offering them in TM would be likely to change the balance. |
| Rick Kronick | Disagree | 6 | I don’t think the growth in MA enrollment growth has primarily been driven by increases in MA rebates. And to the extent that rebates are an important part of MA enrollment growth, the financial benefits of MA (the out-of-pocket maximum, lower deductibles, fixed copayments rather than coinsurance, no Part D premium for most MA plans) likely matter more than the limited vision and dental coverage that MA plans provide. |
| Valerie Lewis | Uncertain | 10 | Have not read the literature on this. I think this could help but I’m skeptical that many beneficiaries are choosing MA plans solely due to these benefits such that this change alone would substantially change enrollment. |
| Nicole Maestas | Uncertain | 9 | Maybe. Cost-sharing in TM would still be a deterrant. |
| Tom McGuire | Disagree | 7 | |
| Ellen Meara | Strongly disagree | 9 | Traditional Medicare has substantial cost sharing while MA offers many zero premium low cost sharing plans. Dental & vision won’t be enough to move people. |
| Ateev Mehrotra | Uncertain | 5 | Unclear the degree to which these benefits are critical in driving choice of plans. |
| David Meltzer | Agree | 8 | |
| Joseph Newhouse | Uncertain | 10 | It depends on how one defines “substantial.” Adding dental and vision would almost certainly cause some switching, but how much would depend on any remaining difference in the generosity of the benefits. Those benefits already differ across MA plans. In addition, many could be deterred by medical rating of supplemental plans. |
| Sean Nicholson | Agree | 5 | |
| Steve Parente | Uncertain | 7 | Traditional Medicare has lousy consumer engagement compared to MA |
| Stephen Patrick | Strongly Agree | 8 | |
| Harold Pollack | Agree | 4 | This is an excellent idea, independent of patient selection across plans. Many traditional Medicare participants have unmet vision and dental needs. |
| Daniel Polsky | Strongly Agree | 9 | The popularity of MA is tied to its relative generosity which is as much a function of MA becoming more generous as it is about TM becoming less generous (as vision and dental costs become a more meaningful financial exposure). |
| Ninez Ponce | Uncertain | 5 | |
| Thomas Rice | Agree | 7 | |
| Meredith Rosenthal | Disagree | 8 | This could have a small effect but “substantially” seems like a stretch. |
| Joseph Ross | Strongly Agree | 9 | |
| Brendan Saloner | Agree | 5 | |
| Kosali Simon | Strongly Agree | 7 | |
| Jon Skinner | Strongly Agree | 8 | |
| Ben Sommers | Agree | 7 | |
| Neeraj Sood | Agree | 7 | |
| David Stevenson | Strongly Agree | 8 | |
| Kevin Volpp | Disagree | 7 | |
| Rachel Werner | Uncertain | 5 |